Mon 2/19/2018 22:20 ET
DJIA25219.3819.010.08%SOLAR24.840.220.89%GOLD1344.1012.100.90%Shanghai3199.1614.400.45%
S&P 5002732.221.090.04%BANKS28.980.040.14%OIL62.190.641.03%BITCOIN11369.55189.871.67%
NASDAQ7239.4716.650.23%SEMI102.790.220.21%US/EU1.240.000.08%Futures2730.254.750.17%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Sorrento Therapeutics, Inc - SRNE)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SRNE
  
From: singhtelecom (Rep: 959)Date: 04/20/2017 02:47
Forum: Wall Street Pit - Msg #2671675 - List SRNE msgs Thread #673922280 (Rec: 0)
Great Entry below 2 imo for 1 year hold ZTlido is a branded, non-aqueous, topical lidocaine patch for pain
associated with post-herpetic neuralgia
› Benefits vs. market leader, Lidoderm®, and other pain patches
o Thin, pliable non-aqueous patch w/ 36 mg of drug to deliver
therapeutic dose vs. Lidoderm, a thick, aqueous patch w/ 700 mg
of drug to deliver therapeutic dose
o Greater adhesion to the skin based on multiple adhesion studies
̶ 90% adhesion in 90% of subjects over 12 hours (no marketed
patches have such data)
̶ No meaningful impact to PK during and after exercise
o Less drug required to administer therapeutic dose, provides cost
advantage in a largely genericized market
› US pain patch market(1) = ~$700mm in 2015
o Potential tailwind from significant demand for abuse-deterrent
alternatives for pain management
› NDA resubmission expected in mid 2017, with potential approval
in 2H17 (2 to 6 month review)
http://sorrentotherapeutics.com/wp-content/uploads/2017/03/Sorrento-Corporate-Presentation-ROTH-Mar-2017-FINAL.pdf

NOTE: This message has been revised 1 time. Read original version of this message.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreSRNE: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SRNE
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.